Annual Accounts Payable
$2.03 M
+$1.46 M+256.67%
December 31, 2023
Summary
- As of February 12, 2025, QNCX annual accounts payable is $2.03 million, with the most recent change of +$1.46 million (+256.67%) on December 31, 2023.
- During the last 3 years, QNCX annual accounts payable has fallen by -$1.52 million (-42.81%).
- QNCX annual accounts payable is now -58.60% below its all-time high of $4.91 million, reached on December 31, 2021.
Performance
QNCX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.62 M
-$783.00 K-32.56%
September 30, 2024
Summary
- As of February 12, 2025, QNCX quarterly accounts payable is $1.62 million, with the most recent change of -$783.00 thousand (-32.56%) on September 30, 2024.
- Over the past year, QNCX quarterly accounts payable has dropped by -$411.00 thousand (-20.22%).
- QNCX quarterly accounts payable is now -77.45% below its all-time high of $7.19 million, reached on June 30, 2021.
Performance
QNCX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
QNCX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +256.7% | -20.2% |
| 3 y3 years | -42.8% | -20.2% |
| 5 y5 years | +310.7% | -20.2% |
QNCX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.6% | +256.7% | -67.0% | +359.5% |
| 5 y | 5-year | -58.6% | +256.7% | -77.5% | +359.5% |
| alltime | all time | -58.6% | +310.7% | -77.5% | +359.5% |
Quince Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.62 M(-32.6%) |
| Jun 2024 | - | $2.40 M(+16.2%) |
| Mar 2024 | - | $2.07 M(+1.8%) |
| Dec 2023 | $2.03 M(+256.7%) | $2.03 M(+397.1%) |
| Sep 2023 | - | $409.00 K(+15.9%) |
| Jun 2023 | - | $353.00 K(-78.6%) |
| Mar 2023 | - | $1.65 M(+189.6%) |
| Dec 2022 | $570.00 K(-88.4%) | $570.00 K(-51.7%) |
| Sep 2022 | - | $1.18 M(-36.7%) |
| Jun 2022 | - | $1.87 M(-50.0%) |
| Mar 2022 | - | $3.73 M(-24.0%) |
| Dec 2021 | $4.91 M | $4.91 M(+70.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $2.88 M(-60.0%) |
| Jun 2021 | - | $7.19 M(+152.8%) |
| Mar 2021 | - | $2.85 M(-20.0%) |
| Dec 2020 | $3.56 M(+15.6%) | $3.56 M(-17.5%) |
| Sep 2020 | - | $4.31 M(-15.4%) |
| Jun 2020 | - | $5.09 M(+2.8%) |
| Mar 2020 | - | $4.95 M(+61.1%) |
| Dec 2019 | $3.08 M(+521.2%) | $3.08 M(+34.0%) |
| Sep 2019 | - | $2.29 M(-55.1%) |
| Jun 2019 | - | $5.12 M(+162.9%) |
| Mar 2019 | - | $1.95 M(+293.1%) |
| Dec 2018 | $495.00 K(-4.3%) | $495.00 K |
| Dec 2017 | $517.00 K | - |
FAQ
- What is Quince Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Quince Therapeutics?
- What is Quince Therapeutics annual accounts payable year-on-year change?
- What is Quince Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Quince Therapeutics?
- What is Quince Therapeutics quarterly accounts payable year-on-year change?
What is Quince Therapeutics annual accounts payable?
The current annual accounts payable of QNCX is $2.03 M
What is the all time high annual accounts payable for Quince Therapeutics?
Quince Therapeutics all-time high annual accounts payable is $4.91 M
What is Quince Therapeutics annual accounts payable year-on-year change?
Over the past year, QNCX annual accounts payable has changed by +$1.46 M (+256.67%)
What is Quince Therapeutics quarterly accounts payable?
The current quarterly accounts payable of QNCX is $1.62 M
What is the all time high quarterly accounts payable for Quince Therapeutics?
Quince Therapeutics all-time high quarterly accounts payable is $7.19 M
What is Quince Therapeutics quarterly accounts payable year-on-year change?
Over the past year, QNCX quarterly accounts payable has changed by -$411.00 K (-20.22%)